questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines et peptides de signalisation intracellulaire
Sirtuines
Sirtuine-1
Sirtuine-1 : Questions médicales fréquentes
Termes MeSH sélectionnés :
Platelet Aggregation Inhibitors
Diagnostic
5
Sirtuine-1
Biopsie
Analyse sanguine
Protéomique
Analyse biochimique
Sirtuine-1
Biomarqueurs
NAD+
Sirtuine-1
Génétique
Expression génique
Sirtuine-1
Immunohistochimie
Tissu
Sirtuine-1
Symptômes
5
Troubles métaboliques
Inflammation
Sirtuine-1
Vieillissement
Longévité
Sirtuine-1
Santé mentale
Cognition
Sirtuine-1
Diabète
Maladies neurodégénératives
Sirtuine-1
Énergie cellulaire
Métabolisme
Sirtuine-1
Prévention
5
Mode de vie sain
Nutrition
Exercice physique
Stress
Expression cellulaire
Sirtuine-1
Tabagisme
Alimentation
Sirtuine-1
Sommeil
Qualité du sommeil
Sirtuine-1
Suppléments
Resvératrol
Sirtuine-1
Traitements
5
Resvératrol
Exercice physique
Sirtuine-1
Médicaments
Modulation
Sirtuine-1
Nutrition
Polyphénols
Sirtuine-1
Exercice physique
Niveaux de Sirtuine-1
Santé
Thérapie génique
Recherche
Sirtuine-1
Complications
5
Maladies métaboliques
Troubles neurodégénératifs
Sirtuine-1
Maladies cardiovasculaires
Risque
Sirtuine-1
Diabète de type 2
Résistance à l'insuline
Sirtuine-1
Cancer
Progression
Sirtuine-1
Alzheimer
Parkinson
Sirtuine-1
Facteurs de risque
5
Obésité
Vieillissement
Stress chronique
Alimentation
Nutriments
Sirtuine-1
Mode de vie sédentaire
Risque
Sirtuine-1
Tabagisme
Diminution
Sirtuine-1
Stress oxydatif
Santé cellulaire
Sirtuine-1
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Sirtuine-1 : Questions médicales les plus fréquentes",
"headline": "Sirtuine-1 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Sirtuine-1 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-13",
"dateModified": "2025-04-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Sirtuine-1"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Sirtuines",
"url": "https://questionsmedicales.fr/mesh/D037761",
"about": {
"@type": "MedicalCondition",
"name": "Sirtuines",
"code": {
"@type": "MedicalCode",
"code": "D037761",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.900"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Sirtuine-1",
"alternateName": "Sirtuin 1",
"code": {
"@type": "MedicalCode",
"code": "D056564",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Giulia Bononi",
"url": "https://questionsmedicales.fr/author/Giulia%20Bononi",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacy, University of Pisa Via Bonanno 6 56126 Pisa Italy giulia.bononi@farm.unipi.it valentina.citi@unipi.it alma.martelli@unipi.it giulio.poli@unipi.it tiziano.tuccinardi@unipi.it carlotta.granchi@unipi.it lara.testai@unipi.it vincenzo.calderone@unipi.it filippo.minutolo@unipi.it."
}
},
{
"@type": "Person",
"name": "Valentina Citi",
"url": "https://questionsmedicales.fr/author/Valentina%20Citi",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacy, University of Pisa Via Bonanno 6 56126 Pisa Italy giulia.bononi@farm.unipi.it valentina.citi@unipi.it alma.martelli@unipi.it giulio.poli@unipi.it tiziano.tuccinardi@unipi.it carlotta.granchi@unipi.it lara.testai@unipi.it vincenzo.calderone@unipi.it filippo.minutolo@unipi.it."
}
},
{
"@type": "Person",
"name": "Alma Martelli",
"url": "https://questionsmedicales.fr/author/Alma%20Martelli",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacy, University of Pisa Via Bonanno 6 56126 Pisa Italy giulia.bononi@farm.unipi.it valentina.citi@unipi.it alma.martelli@unipi.it giulio.poli@unipi.it tiziano.tuccinardi@unipi.it carlotta.granchi@unipi.it lara.testai@unipi.it vincenzo.calderone@unipi.it filippo.minutolo@unipi.it."
}
},
{
"@type": "Person",
"name": "Giulio Poli",
"url": "https://questionsmedicales.fr/author/Giulio%20Poli",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacy, University of Pisa Via Bonanno 6 56126 Pisa Italy giulia.bononi@farm.unipi.it valentina.citi@unipi.it alma.martelli@unipi.it giulio.poli@unipi.it tiziano.tuccinardi@unipi.it carlotta.granchi@unipi.it lara.testai@unipi.it vincenzo.calderone@unipi.it filippo.minutolo@unipi.it."
}
},
{
"@type": "Person",
"name": "Tiziano Tuccinardi",
"url": "https://questionsmedicales.fr/author/Tiziano%20Tuccinardi",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacy, University of Pisa Via Bonanno 6 56126 Pisa Italy giulia.bononi@farm.unipi.it valentina.citi@unipi.it alma.martelli@unipi.it giulio.poli@unipi.it tiziano.tuccinardi@unipi.it carlotta.granchi@unipi.it lara.testai@unipi.it vincenzo.calderone@unipi.it filippo.minutolo@unipi.it."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Inhibition of platelet aggregation by activation of platelet intermediate conductance Ca",
"datePublished": "2022-08-07",
"url": "https://questionsmedicales.fr/article/35867883",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jth.15827"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Inhibition of platelet aggregation (Update 2023)].",
"datePublished": "2023-04-20",
"url": "https://questionsmedicales.fr/article/37101038",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00508-023-02168-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Coumarin Derivatives Inhibit ADP-Induced Platelet Activation and Aggregation.",
"datePublished": "2022-06-23",
"url": "https://questionsmedicales.fr/article/35807298",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/molecules27134054"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Peri-interventional management of platelet aggregation inhibition and anticoagulation in urology].",
"datePublished": "2022-08-02",
"url": "https://questionsmedicales.fr/article/35925116",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00120-022-01916-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Multicenter evaluation of light transmission platelet aggregation reagents: communication from the ISTH SSC Subcommittee on Platelet Physiology.",
"datePublished": "2023-06-16",
"url": "https://questionsmedicales.fr/article/37331519",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jtha.2023.05.027"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines et peptides de signalisation intracellulaire",
"item": "https://questionsmedicales.fr/mesh/D047908"
},
{
"@type": "ListItem",
"position": 5,
"name": "Sirtuines",
"item": "https://questionsmedicales.fr/mesh/D037761"
},
{
"@type": "ListItem",
"position": 6,
"name": "Sirtuine-1",
"item": "https://questionsmedicales.fr/mesh/D056564"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Sirtuine-1 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Sirtuine-1",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Sirtuine-1",
"description": "Comment évaluer le niveau de Sirtuine-1 ?\nQuels tests sont utilisés pour la Sirtuine-1 ?\nY a-t-il des biomarqueurs associés à Sirtuine-1 ?\nLa génétique influence-t-elle Sirtuine-1 ?\nPeut-on mesurer Sirtuine-1 dans les tissus ?",
"url": "https://questionsmedicales.fr/mesh/D056564?mesh_terms=Platelet+Aggregation+Inhibitors#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Sirtuine-1",
"description": "Quels symptômes sont liés à une faible Sirtuine-1 ?\nLa Sirtuine-1 affecte-t-elle le vieillissement ?\nQuels effets sur la santé mentale ?\nY a-t-il des symptômes de maladies liées à Sirtuine-1 ?\nSirtuine-1 influence-t-elle l'énergie cellulaire ?",
"url": "https://questionsmedicales.fr/mesh/D056564?mesh_terms=Platelet+Aggregation+Inhibitors#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Sirtuine-1",
"description": "Comment prévenir la baisse de Sirtuine-1 ?\nLe stress affecte-t-il Sirtuine-1 ?\nY a-t-il des habitudes à éviter ?\nLe sommeil influence-t-il Sirtuine-1 ?\nDes suppléments pour Sirtuine-1 ?",
"url": "https://questionsmedicales.fr/mesh/D056564?mesh_terms=Platelet+Aggregation+Inhibitors#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Sirtuine-1",
"description": "Quels traitements augmentent Sirtuine-1 ?\nY a-t-il des médicaments ciblant Sirtuine-1 ?\nComment la nutrition affecte-t-elle Sirtuine-1 ?\nL'exercice physique influence-t-il Sirtuine-1 ?\nDes thérapies géniques pour Sirtuine-1 ?",
"url": "https://questionsmedicales.fr/mesh/D056564?mesh_terms=Platelet+Aggregation+Inhibitors#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Sirtuine-1",
"description": "Quelles complications sont liées à une faible Sirtuine-1 ?\nSirtuine-1 et maladies cardiovasculaires ?\nY a-t-il un lien avec le diabète ?\nSirtuine-1 et cancer ?\nComplications neurologiques liées à Sirtuine-1 ?",
"url": "https://questionsmedicales.fr/mesh/D056564?mesh_terms=Platelet+Aggregation+Inhibitors#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Sirtuine-1",
"description": "Quels facteurs augmentent le risque de faible Sirtuine-1 ?\nL'alimentation influence-t-elle Sirtuine-1 ?\nLe mode de vie sédentaire affecte-t-il Sirtuine-1 ?\nLe tabagisme impacte-t-il Sirtuine-1 ?\nLe stress oxydatif influence-t-il Sirtuine-1 ?",
"url": "https://questionsmedicales.fr/mesh/D056564?mesh_terms=Platelet+Aggregation+Inhibitors#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer le niveau de Sirtuine-1 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le niveau de Sirtuine-1 peut être mesuré par des tests sanguins ou des biopsies tissulaires."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour la Sirtuine-1 ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests biochimiques et des analyses protéomiques sont utilisés pour évaluer Sirtuine-1."
}
},
{
"@type": "Question",
"name": "Y a-t-il des biomarqueurs associés à Sirtuine-1 ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des biomarqueurs comme les niveaux de NAD+ peuvent être associés à Sirtuine-1."
}
},
{
"@type": "Question",
"name": "La génétique influence-t-elle Sirtuine-1 ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des variations génétiques peuvent affecter l'expression de Sirtuine-1."
}
},
{
"@type": "Question",
"name": "Peut-on mesurer Sirtuine-1 dans les tissus ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, Sirtuine-1 peut être mesurée dans des échantillons de tissus par immunohistochimie."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une faible Sirtuine-1 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une faible Sirtuine-1 peut être associée à des troubles métaboliques et à l'inflammation."
}
},
{
"@type": "Question",
"name": "La Sirtuine-1 affecte-t-elle le vieillissement ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, Sirtuine-1 est impliquée dans la régulation du vieillissement cellulaire et de la longévité."
}
},
{
"@type": "Question",
"name": "Quels effets sur la santé mentale ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux de Sirtuine-1 peuvent influencer l'humeur et la cognition."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes de maladies liées à Sirtuine-1 ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète et les maladies neurodégénératives sont liées à Sirtuine-1."
}
},
{
"@type": "Question",
"name": "Sirtuine-1 influence-t-elle l'énergie cellulaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, Sirtuine-1 joue un rôle clé dans la régulation de l'énergie cellulaire et du métabolisme."
}
},
{
"@type": "Question",
"name": "Comment prévenir la baisse de Sirtuine-1 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain avec une bonne nutrition et de l'exercice aide à prévenir la baisse."
}
},
{
"@type": "Question",
"name": "Le stress affecte-t-il Sirtuine-1 ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut réduire l'expression de Sirtuine-1 dans les cellules."
}
},
{
"@type": "Question",
"name": "Y a-t-il des habitudes à éviter ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme et une alimentation riche en sucres peut aider à maintenir Sirtuine-1."
}
},
{
"@type": "Question",
"name": "Le sommeil influence-t-il Sirtuine-1 ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un sommeil de qualité est essentiel pour maintenir des niveaux optimaux de Sirtuine-1."
}
},
{
"@type": "Question",
"name": "Des suppléments pour Sirtuine-1 ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments comme le resvératrol peuvent être bénéfiques pour soutenir Sirtuine-1."
}
},
{
"@type": "Question",
"name": "Quels traitements augmentent Sirtuine-1 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements comme le resvératrol et l'exercice physique peuvent augmenter Sirtuine-1."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments ciblant Sirtuine-1 ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments expérimentaux visent à moduler l'activité de Sirtuine-1."
}
},
{
"@type": "Question",
"name": "Comment la nutrition affecte-t-elle Sirtuine-1 ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en polyphénols peut stimuler l'expression de Sirtuine-1."
}
},
{
"@type": "Question",
"name": "L'exercice physique influence-t-il Sirtuine-1 ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier est connu pour augmenter les niveaux de Sirtuine-1 dans le corps."
}
},
{
"@type": "Question",
"name": "Des thérapies géniques pour Sirtuine-1 ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches sont en cours sur les thérapies géniques pour moduler Sirtuine-1."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées à une faible Sirtuine-1 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une faible Sirtuine-1 est liée à des maladies métaboliques et à des troubles neurodégénératifs."
}
},
{
"@type": "Question",
"name": "Sirtuine-1 et maladies cardiovasculaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux bas de Sirtuine-1 peuvent augmenter le risque de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien avec le diabète ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une faible Sirtuine-1 est associée à une résistance à l'insuline et au diabète de type 2."
}
},
{
"@type": "Question",
"name": "Sirtuine-1 et cancer ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent que Sirtuine-1 pourrait jouer un rôle dans la progression de certains cancers."
}
},
{
"@type": "Question",
"name": "Complications neurologiques liées à Sirtuine-1 ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une dysrégulation de Sirtuine-1 est liée à des maladies comme Alzheimer et Parkinson."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de faible Sirtuine-1 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, le vieillissement et le stress chronique augmentent le risque de faible Sirtuine-1."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle Sirtuine-1 ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation pauvre en nutriments peut réduire l'expression de Sirtuine-1."
}
},
{
"@type": "Question",
"name": "Le mode de vie sédentaire affecte-t-il Sirtuine-1 ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire est un facteur de risque pour une faible Sirtuine-1."
}
},
{
"@type": "Question",
"name": "Le tabagisme impacte-t-il Sirtuine-1 ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est associé à une diminution des niveaux de Sirtuine-1 dans l'organisme."
}
},
{
"@type": "Question",
"name": "Le stress oxydatif influence-t-il Sirtuine-1 ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress oxydatif peut réduire l'activité de Sirtuine-1 et affecter la santé cellulaire."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 08/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Pharmacy, University of Pisa Via Bonanno 6 56126 Pisa Italy giulia.bononi@farm.unipi.it valentina.citi@unipi.it alma.martelli@unipi.it giulio.poli@unipi.it tiziano.tuccinardi@unipi.it carlotta.granchi@unipi.it lara.testai@unipi.it vincenzo.calderone@unipi.it filippo.minutolo@unipi.it.
Publications dans "Sirtuine-1" :
3 publications dans cette catégorie
Affiliations :
Department of Pharmacy, University of Pisa Via Bonanno 6 56126 Pisa Italy giulia.bononi@farm.unipi.it valentina.citi@unipi.it alma.martelli@unipi.it giulio.poli@unipi.it tiziano.tuccinardi@unipi.it carlotta.granchi@unipi.it lara.testai@unipi.it vincenzo.calderone@unipi.it filippo.minutolo@unipi.it.
Publications dans "Sirtuine-1" :
3 publications dans cette catégorie
Affiliations :
Department of Pharmacy, University of Pisa Via Bonanno 6 56126 Pisa Italy giulia.bononi@farm.unipi.it valentina.citi@unipi.it alma.martelli@unipi.it giulio.poli@unipi.it tiziano.tuccinardi@unipi.it carlotta.granchi@unipi.it lara.testai@unipi.it vincenzo.calderone@unipi.it filippo.minutolo@unipi.it.
Center for Instrument Sharing of the University of Pisa (CISUP) Lungarno Pacinotti 43 56126 Pisa Italy.
Publications dans "Sirtuine-1" :
3 publications dans cette catégorie
Affiliations :
Department of Pharmacy, University of Pisa Via Bonanno 6 56126 Pisa Italy giulia.bononi@farm.unipi.it valentina.citi@unipi.it alma.martelli@unipi.it giulio.poli@unipi.it tiziano.tuccinardi@unipi.it carlotta.granchi@unipi.it lara.testai@unipi.it vincenzo.calderone@unipi.it filippo.minutolo@unipi.it.
Publications dans "Sirtuine-1" :
3 publications dans cette catégorie
Affiliations :
Department of Pharmacy, University of Pisa Via Bonanno 6 56126 Pisa Italy giulia.bononi@farm.unipi.it valentina.citi@unipi.it alma.martelli@unipi.it giulio.poli@unipi.it tiziano.tuccinardi@unipi.it carlotta.granchi@unipi.it lara.testai@unipi.it vincenzo.calderone@unipi.it filippo.minutolo@unipi.it.
Center for Instrument Sharing of the University of Pisa (CISUP) Lungarno Pacinotti 43 56126 Pisa Italy.
Publications dans "Sirtuine-1" :
3 publications dans cette catégorie
Affiliations :
Department of Pharmacy, University of Pisa Via Bonanno 6 56126 Pisa Italy giulia.bononi@farm.unipi.it valentina.citi@unipi.it alma.martelli@unipi.it giulio.poli@unipi.it tiziano.tuccinardi@unipi.it carlotta.granchi@unipi.it lara.testai@unipi.it vincenzo.calderone@unipi.it filippo.minutolo@unipi.it.
Center for Instrument Sharing of the University of Pisa (CISUP) Lungarno Pacinotti 43 56126 Pisa Italy.
Publications dans "Sirtuine-1" :
3 publications dans cette catégorie
Affiliations :
Department of Pharmacy, University of Pisa Via Bonanno 6 56126 Pisa Italy giulia.bononi@farm.unipi.it valentina.citi@unipi.it alma.martelli@unipi.it giulio.poli@unipi.it tiziano.tuccinardi@unipi.it carlotta.granchi@unipi.it lara.testai@unipi.it vincenzo.calderone@unipi.it filippo.minutolo@unipi.it.
Center for Instrument Sharing of the University of Pisa (CISUP) Lungarno Pacinotti 43 56126 Pisa Italy.
Publications dans "Sirtuine-1" :
3 publications dans cette catégorie
Affiliations :
Department of Pharmacy, University of Pisa Via Bonanno 6 56126 Pisa Italy giulia.bononi@farm.unipi.it valentina.citi@unipi.it alma.martelli@unipi.it giulio.poli@unipi.it tiziano.tuccinardi@unipi.it carlotta.granchi@unipi.it lara.testai@unipi.it vincenzo.calderone@unipi.it filippo.minutolo@unipi.it.
Center for Instrument Sharing of the University of Pisa (CISUP) Lungarno Pacinotti 43 56126 Pisa Italy.
Publications dans "Sirtuine-1" :
3 publications dans cette catégorie
Affiliations :
Department of Pharmacy, University of Pisa Via Bonanno 6 56126 Pisa Italy giulia.bononi@farm.unipi.it valentina.citi@unipi.it alma.martelli@unipi.it giulio.poli@unipi.it tiziano.tuccinardi@unipi.it carlotta.granchi@unipi.it lara.testai@unipi.it vincenzo.calderone@unipi.it filippo.minutolo@unipi.it.
Center for Instrument Sharing of the University of Pisa (CISUP) Lungarno Pacinotti 43 56126 Pisa Italy.
Publications dans "Sirtuine-1" :
2 publications dans cette catégorie
Affiliations :
Institute of Animal Reproduction and Food Research of the Polish Academy of Sciences, Tuwima 10, 10-748 Olsztyn, Poland.
Publications dans "Sirtuine-1" :
2 publications dans cette catégorie
Affiliations :
Department of Animal Sciences, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot 761001, Israel.
Publications dans "Sirtuine-1" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry, University of Bayreuth, 95440 Bayreuth, Germany.
Publications dans "Sirtuine-1" :
2 publications dans cette catégorie
Affiliations :
Department of Biopolymers, University of Bayreuth, 95440 Bayreuth, Germany.
Publications dans "Sirtuine-1" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry, University of Bayreuth, 95440 Bayreuth, Germany.
Publications dans "Sirtuine-1" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, India.
Publications dans "Sirtuine-1" :
2 publications dans cette catégorie
Affiliations :
2nd Department of Nephrology and Hypertension with Dialysis Unit, Medical University of Bialystok, Bialystok, Poland.
Publications dans "Sirtuine-1" :
2 publications dans cette catégorie
Affiliations :
2nd Department of Nephrology and Hypertension with Dialysis Unit, Medical University of Bialystok, Bialystok, Poland.
Publications dans "Sirtuine-1" :
2 publications dans cette catégorie
Affiliations :
Chitkara College of Pharmacy, Chitkara University, 140401, Punjab, India.
Publications dans "Sirtuine-1" :
1 publication dans cette catégorie
Affiliations :
School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Publications dans "Sirtuine-1" :
1 publication dans cette catégorie
Affiliations :
School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Publications dans "Sirtuine-1" :
Within the vasculature platelets and endothelial cells play crucial roles in hemostasis and thrombosis. Platelets, like endothelial cells, possess intermediate conductance Ca...
We investigated whether IK...
Platelets were isolated from human volunteers. Aggregometry, confocal microscopy, and a novel flow chamber model, the Quartz Crystal Microbalance (QCM) were used to assess platelet function. Flow cyto...
Platelet IK...
Platelet IK...
Acute thrombotic complications as a key feature of accelerated atherothrombotic disease typically precipitate cardiovascular events and therefore strongly contribute to cardiovascular morbidity and mo...
Coumarin was first discovered in Tonka bean and then widely in other plants. Coumarin has an anticoagulant effect, and its derivative, warfarin, is a vitamin K analogue that inhibits the synthesis of ...
Perioperative management of anticoagulation in patients receiving long-term anticoagulation or platelet aggregation inhibitors requires an individual consideration of competing risks. If the risk for ...
Light transmission aggregation (LTA) is used widely by the clinical and research communities. Although it is a gold standard, there is a lack of interlaboratory harmonization....
The primary objective was to assess whether sources of activators (mainly adenosine diphosphate [ADP], collagen, arachidonic acid, epinephrine, and thrombin receptor activating peptide6) and ristoceti...
An international multicenter study involving 28 laboratories in which we compared LTA results obtained with center-specific activators and a comparator that we supplied....
We report variability in the potency (P) of activators in comparison with the comparator. Thrombin receptor activating peptide 6 (P, 1.32-2.68), arachidonic acid (P, 0.87-1.43), and epinephrine (P, 0....
Based on these data, the establishment and adoption of simple standardization principles should mitigate variability due to activator sources. The observation of huge interindividual variability for c...
Platelets are the "guardians" of the blood circulatory system. At sites of vessel injury, they ensure hemostasis and promote immunity and vessel repair. However, their uncontrolled activation is one o...
Isoquinoline alkaloids have multiple biological activities, which might be associated with positive pharmacological effects as well as negative adverse reactions. As bleeding was suggested to be a sid...
Disintegrins are small peptides possessing a tripeptide motif capable of binding to integrins. These were first isolated from viper venoms and are now also found in many other hematophagous organisms....
It is currently believed that plaque complication, with the consequent superimposed thrombosis, is a key factor in the clinical occurrence of acute coronary syndromes (ACSs). Platelets are major playe...
We aimed to investigate the effects of integrin αIIbβ3 inhibitor tirofiban on hallmarks of platelet activation, degranulation, and aggregation during its use to analyze activated but non-complexed pla...